Preliminary Findings from the Swedish Myasthenia Gravis Registry
Wanqing Wu, a PhD student from Karolinska Institute, discusses the Swedish Myasthenia Gravis (MG) Registry at the EAN 2024. Initiated in 2011, the registry includes over 1,700 MG patients, representing about 60% of Sweden’s MG population. Preliminary findings include the average age of MG onset at 50 years, common antibody presence, and significant use of rituximab.
Få tillgång
Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.
- Få tillgång
- Om du redan har en profil: Logga in